GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Results] 62 weeks, 45kg, and FLOW was the hard part — 46 comments in the full submission. View in context.
3.6k
c/trialwatch·submitted 4 months ago by u/aurel_mwangi

[Results] 62 weeks, 45kg, and FLOW was the hard part

Trial Databranch of 17 comments

Right, the TRIUMPH question again, but with numbers this time. I have 16 data points over 24 weeks. The pattern is consistent enough that I do not think it is chance, and boring enough that nobody is going to screenshot it, which is usually a good sign. The thing I would flag for anyone new: the effect I am…

Read the full submission and all 46 comments →

This branch

17 comments, started 4 months ago
u/heart_rate_bump130 points·4 months ago

STEP, SURMOUNT, SURPASS, SELECT, FLOW, TRIUMPH — read the appendix

replysharereportpermalink
u/paper_trail_paulavetting65 points·4 months ago

The practical rule people converge on is 28 days at fridge temperature after first puncture, and that comes from the preservative, not the peptide.

replysharereportpermalink
u/laila_almeida22 points·4 months ago·edited

phase 2 is not phase 3, smaller n and shorter trial

replysharereportpermalink
u/nils_tulloch70 points·4 months ago

Phase 2 or phase 3?

replysharereportpermalink
u/camila_vasquez59 points·4 months ago

the 7 week readout is different from the 28 week readout

replysharereportpermalink
u/aurel_mwangiOP93 points·4 months ago

SURMOUNT-4 discontinuation arm showed regain. That is the reality of a chronic disease treatment, not a failure.

replysharereportpermalink
u/blunt_coldbox_notes24 points·4 months ago

Yeah, absolute numbers matter more than the press release.

replysharereportpermalink
u/hedda_adeyemi-8 points·4 months ago

the discontinuation arms are the interesting part, not the STEP endpoints

replysharereportpermalink
u/nora_oyelaran0 points·4 months ago

off-label use data is different from approved-indication data

replysharereportpermalink
u/whois_wanda109 points·4 months ago

SURMOUNT-4 discontinuation arm showed regain.

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

replysharereportpermalink
u/yannick_salinas26 points·4 months ago

the discontinuation arms are the interesting part, not the endpoint endpoints

replysharereportpermalink
load more comments (6) →

← back to the whole thread

About c/trialwatch

Clinical trial reading group. New readouts, protocol amendments, endpoint definitions, dropout handling, and the difference between a press release and a publication. Absolute risk reduction and number-needed-to-treat are house dialect here.

34kmembers
95submissions
Nov 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/trialwatch rules
  1. Press-release-only posts must be flaired Press Release until a publication exists.
  2. Give the trial name, phase, n, and primary endpoint in the body.
  3. Relative risk reduction alone is not a result. Show the absolute numbers.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.